Gifu Pharmaceutical University · Laboratory of Advanced Medical Pharmaceutical Sciences · 准教授

Research keywordsEvidence-practice gap，Efficacy and Safety of Pharmacotherapy・医療薬学・環境系薬学

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy.
• Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.
• Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.
• Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial.

• 小児がん患者に対する口内炎予防薬ポラプレジンク含有粘膜付着性フィルム製剤の開発
• オランザピンの抗がん剤誘発性悪心・嘔吐に対する臨床的有効性とその作用機序の解明
• 血管内皮障害に着目した化学療法誘発性末梢神経障害に対する新規予防・治療戦略
• がん治療における口内炎に対する新規開発ポラプレジンク含有トローチ製剤の予防効果

• Official profile